TG Therapeutics, Inc. (LON:0VGI)

London · Delayed Price · Currency is GBP · Price in USD

37.11

+9.04 (32.21%)

At close: Oct 1, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Novel Treatments for B-cell Diseases	329.00M	Log In	Log In	Log In	Log In	Upgrade
Novel Treatments for B-cell Diseases Growth	40.80%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	329.00M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	40.80%	Log In	Log In	Log In	Log In	Upgrade